CS logo
small CS logo
King Chulalongkorn Memorial Hospital

Pathum Wan, Bangkok, Thailand
Hospital in Bangkok
1873 Rama IV Rd, Pathum Wan, Bangkok 10330
1,435 Beds

About King Chulalongkorn Memorial Hospital


King Chulalongkorn Memorial Hospital is a public general and tertiary referral hospital in Bangkok, Thailand. It is operated by the Thai Red Cross Society, and serves as the teaching hospital for the Faculty of Medicine, Chulalongkorn University and Srisavarindhira Thai Red Cross Institute of Nursing.
There are 1,435 beds in King Chulalongkorn Memorial Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Chulalongkorn University
6
King Chulalongkorn Memorial Hospital
3
EMD Serono Research & Development Institute, Inc.
2
F2G Biotech GmbH
2
Arena Pharmaceuticals
1
Boston Scientific Corporation
1
Pfizer
1
Total Rows: 7

Clinical Trials at King Chulalongkorn Memorial Hospital


During the past decade, King Chulalongkorn Memorial Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22001133112200220000000000001111Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of Honan Balloon in Intraocular Pressure Reduction Before Phacoemulsification
2005-12-01
2006-07-01
Completed
Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital
2008-02-01
2009-07-01
Completed
172
Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Between Prone and Left Lateral Decubitus
2009-07-01
2010-01-01
Completed
40
Dual Focus NBI and pCLE in FAP Related Duodenal Adenoma
2012-12-01
Completed
26
Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT
2014-07-01
2018-06-01
Completed
142
Avelumab in First-line NSCLC (JAVELIN Lung 100)
2015-10-29
2022-12-31
Active, not recruiting
1,214
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
2015-12-24
2021-06-03
Completed
499
Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant
2018-01-01
2018-08-01
Completed
60

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "King Chulalongkorn Memorial Hospital" #1 sponsor was "Chulalongkorn University" with 6 trials, followed by "King Chulalongkorn Memorial Hospital" with 3 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "F2G Biotech GmbH" with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "King Chulalongkorn Memorial Hospital" #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Thammasat University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChulalongkorn University: 6Chulalongkorn University: 6King ChulalongkornMemorial Hospital: 3King ChulalongkornMemorial Hospital: 3EMD Serono Research &Development Institute,Inc.: 2EMD Serono Research &Development Institute,Inc.: 2F2G Biotech GmbH: 2F2G Biotech GmbH: 2Arena Pharmaceuticals: 1Arena Pharmaceuticals: 1Boston Scientific Corporation: 1Boston Scientific Corporation: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsIqvia Pty Ltd: 2Iqvia Pty Ltd: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2Arena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Thammasat University: 1Thammasat University: 1

Clinical Trials Conditions at King Chulalongkorn Memorial Hospital


According to Clinical.Site data, the most researched conditions in "King Chulalongkorn Memorial Hospital" are "Ulcerative Colitis" (2 trials), "Adult-Onset Immunodeficiency With Acquired Anti-Interferon-Gamma Autoantibodies" (1 trials), "Adverse Effect of Diagnostic Agents, Subsequent Encounter" (1 trials), "Atrial Fibrillation" (1 trials) and "Biliary Stones" (1 trials). Many other conditions were trialed in "King Chulalongkorn Memorial Hospital" in a lesser frequency.

Clinical Trials Intervention Types at King Chulalongkorn Memorial Hospital


Most popular intervention types in "King Chulalongkorn Memorial Hospital" are "Drug" (9 trials), "Procedure" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (2 trials), "Etrasimod" (2 trials), "Placebo" (2 trials), "5-Fluorouracil" (1 trials) and "AmBisome®" (1 trials). Other intervention names were less common.

Clinical Trials Genders at King Chulalongkorn Memorial Hospital


The vast majority of trials in "King Chulalongkorn Memorial Hospital" are 14 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at King Chulalongkorn Memorial Hospital


Currently, there are NaN active trials in "King Chulalongkorn Memorial Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in King Chulalongkorn Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in King Chulalongkorn Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Not Applicable: 3Not Applicable: 3Phase 4: 3Phase 4: 3Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 4Recruiting: 4Active, not recruiting: 1Active, not recruiting: 1Enrolling by invitation: 1Enrolling by invitation: 1Unknown status: 1Unknown status: 1